Location Geneva, Geneve, Switzerland Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Tom brings more than two decades of experience in pharmaceutical R&D, latest as Chief Scientific Officer of the rare disease company Wilson Therapeutics. Tom’s previous assignments include senior roles at Serono, Merck, and Shire, where he has worked across multiple therapeutic areas, including neuroinflammatory, metabolic, and rare diseases.
Tom holds a PhD from Technical University of Munich, Germany.
